GLP-1s
US$ 27.21
itching after tirzepatide injection Site Red and Itchy: Causes and Solutions Is Your Injection Site Reaction
Description
doi: 10.1007/s00125-016-4061-x
:max_bytes(150000):strip_icc()/VWH-GettyImages-1665050998-d856556e1272422186a3d2d7c075d9cb.jpg)
This research led to the first long-acting GLP-1-based drug , liraglutide, which was approved by the U.S
An 8-week onboarding study showed some users experienced immediate appetite suppression, while others showed modest changes and more side effects
Besides the trial sub-population being at severe cardiovascular risk, 72% were male, 84% Caucasian and 66% had A1c levels over 5.7 indicating prediabetes
